These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster. Park JS, Hwang SJ, Shin JH, Kim DS. J Neurol Sci; 2013 Nov 15; 334(1-2):69-71. PubMed ID: 23953947 [Abstract] [Full Text] [Related]
6. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. Kitley J, Leite MI, Küker W, Quaghebeur G, George J, Waters P, Woodhall M, Vincent A, Palace J. JAMA Neurol; 2013 Nov 15; 70(11):1375-81. PubMed ID: 23999580 [Abstract] [Full Text] [Related]
9. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Trebst C, Ringelstein M, Aktas O, Winkelmann A, Buttmann M, Schwarz A, Zimmermann H, Brandt AU, Franciotta D, Capobianco M, Kuchling J, Haas J, Korporal-Kuhnke M, Lillevang ST, Fechner K, Schanda K, Paul F, Wildemann B, Reindl M, in cooperation with the Neuromyelitis Optica Study Group (NEMOS). J Neuroinflammation; 2016 Sep 26; 13(1):279. PubMed ID: 27788675 [Abstract] [Full Text] [Related]
10. Role of AQP4 Antibody Serostatus and its Prediction of Visual Outcome in Neuromyelitis Optica: A Systematic Review and Meta-Analysis. Lin N, Liu Q, Wang X, Ma J, Li Y. Protein Pept Lett; 2017 Sep 26; 24(3):245-252. PubMed ID: 28071581 [Abstract] [Full Text] [Related]
11. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti CF, Pittock SJ. Neurology; 2008 Jan 29; 70(5):344-52. PubMed ID: 18094334 [Abstract] [Full Text] [Related]
14. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives. Jasiak-Zatonska M, Kalinowska-Lyszczarz A, Michalak S, Kozubski W. Int J Mol Sci; 2016 Mar 02; 17(3):273. PubMed ID: 26950113 [Abstract] [Full Text] [Related]
15. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. Lechner C, Baumann M, Hennes EM, Schanda K, Marquard K, Karenfort M, Leiz S, Pohl D, Venkateswaran S, Pritsch M, Koch J, Schimmel M, Häusler M, Klein A, Blaschek A, Thiels C, Lücke T, Gruber-Sedlmayr U, Kornek B, Hahn A, Leypoldt F, Sandrieser T, Gallwitz H, Stoffels J, Korenke C, Reindl M, Rostásy K. J Neurol Neurosurg Psychiatry; 2016 Aug 02; 87(8):897-905. PubMed ID: 26645082 [Abstract] [Full Text] [Related]
16. Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies. Chang KH, Lyu RK, Chen CM, Wu YR, Chang HS, Huang CC, Kuo HC, Chu CC, Hsu WC, Ro LS. Mult Scler; 2013 Mar 02; 19(3):299-307. PubMed ID: 22829325 [Abstract] [Full Text] [Related]
17. Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes. Juryńczyk M, Weinshenker B, Akman-Demir G, Asgari N, Barnes D, Boggild M, Chaudhuri A, D'hooghe M, Evangelou N, Geraldes R, Illes Z, Jacob A, Kim HJ, Kleiter I, Levy M, Marignier R, McGuigan C, Murray K, Nakashima I, Pandit L, Paul F, Pittock S, Selmaj K, de Sèze J, Siva A, Tanasescu R, Vukusic S, Wingerchuk D, Wren D, Leite I, Palace J. J Neurol; 2016 Jan 02; 263(1):140-9. PubMed ID: 26530512 [Abstract] [Full Text] [Related]